From: Gene-microRNA network module analysis for ovarian cancer
No. | Enriched Pathways | p-value |
---|---|---|
17 | Cytokine-cytokine receptor interaction | 7.40E-05 |
 | NOD-like receptor signaling pathway | 1.20E-03 |
 | Chemokine signaling pathway | 5.80E-03 |
 | Hematopoietic cell lineage | 3.30E-02 |
 | Complement and coagulation cascades | 1.80E-01 |
 | Systemic lupus erythematosus | 2.70E-01 |
18 | p53 signaling pathway | 3.50E-03 |
 | Small cell lung cancer | 2.70E-03 |
 | Cell cycle | 4.00E-03 |
 | Pathways in cancer | 2.10E-02 |
 | Non-small cell lung cancer | 8.20E-02 |
 | Glioma | 8.00E-02 |
 | Melanoma | 7.70E-02 |
 | Pancreatic cancer | 6.90E-02 |
 | Chronic myeloid leukemia | 6.40E-02 |
 | Prostate cancer | 6.80E-02 |
24 | Cytokine-cytokine receptor interaction | 4.40E-05 |
 | NOD-like receptor signaling pathway | 9.40E-04 |
 | Chemokine signaling pathway | 4.30E-03 |
 | Hematopoietic cell lineage | 2.70E-02 |
 | Complement and coagulation cascades | 1.60E-01 |
 | Systemic lupus erythematosus | 2.40E-01 |
28 | Antigen processing and presentation | 4.00E-03 |
 | Cytokine-cytokine receptor interaction | 1.20E-02 |
 | Natural killer cell mediated cytotoxicity | 9.20E-02 |
 | Hematopoietic cell lineage | 1.30E-01 |
 | Graft-versus-host disease | 1.70E-01 |
 | Chemokine signaling pathway | 1.40E-01 |
 | NOD-like receptor signaling pathway | 2.70E-01 |
 | Viral myocarditis | 3.00E-01 |
31 | Systemic lupus erythematosus | 1.30E-02 |
41 | Small cell lung cancer | 1.30E-03 |
 | Chronic myeloid leukemia | 3.10E-02 |
 | Pathways in cancer | 2.40E-02 |
 | Colorectal cancer | 1.90E-02 |
 | Cell cycle | 3.40E-02 |
 | Thyroid cancer | 1.30E-01 |
 | Bladder cancer | 1.60E-01 |
 | Endometrial cancer | 1.80E-01 |
 | Non-small cell lung cancer | 1.60E-01 |
 | Acute myeloid leukemia | 1.60E-01 |
 | Glioma | 1.60E-01 |
 | p53 signaling pathway | 1.50E-01 |
 | Melanoma | 1.50E-01 |
 | Pancreatic cancer | 1.40E-01 |
 | Prostate cancer | 1.60E-01 |
43 | ECM-receptor interaction | 1.20E-09 |
 | Focal adhesion | 6.70E-06 |
 | Vascular smooth muscle contraction | 1.60E-01 |
21 | Focal adhesion | 8.80E-01 |
22 | ECM-receptor interaction | 8.30E-01 |
35 | Acute myeloid leukemia | 8.20E-01 |
 | p53 signaling pathway | 6.40E-01 |
 | Chronic myeloid leukemia | 5.20E-01 |
37 | Hypertrophic cardiomyopathy (HCM) | 7.00E-02 |
 | Gap junction | 2.70E-01 |
 | Dilated cardiomyopathy | 2.10E-01 |
 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 4.60E-01 |
 | MAPK signaling pathway | 7.80E-01 |
45 | Pathways in cancer | 7.30E-01 |
 | Basal cell carcinoma | 5.00E-01 |
 | Hedgehog signaling pathway | 3.70E-01 |